Postoperative Complications Associated with the Choice of Reconstruction in Head and Neck Cancer: An Outcome Analysis of 4,712 Patients from the ACS-NSQIP Database.


Journal

Journal of reconstructive microsurgery
ISSN: 1098-8947
Titre abrégé: J Reconstr Microsurg
Pays: United States
ID NLM: 8502670

Informations de publication

Date de publication:
Jun 2022
Historique:
pubmed: 18 8 2021
medline: 22 6 2022
entrez: 17 8 2021
Statut: ppublish

Résumé

 Microsurgical free flaps have largely supplanted pedicled flaps as the gold standard for head and neck cancer reconstruction. However, incidence of postoperative complications after accounting for patient comorbidities based on choice of reconstruction has not been well-defined in the literature in recent years.  Patients undergoing head and neck reconstruction were identified in the 2011-2016 ACS-NSQIP (American College of Surgeons National Surgical Quality Improvement Program) database and stratified into groups by free flap, myocutaneous pedicled flap, and other reconstruction. Demographics were analyzed and covariates balanced using overlap propensity score-based weighting. Logistic regression was used for binary outcomes and Gamma generalized linear model was used for length of stay.  A total of 4,712 patients met inclusion criteria out of which 1,297 patients (28%) underwent free flap, 208 patients (4%) pedicled flap, and 3,207 patients (68%) had other, or no reconstruction performed. After adjusting for patient and disease-specific factors, pedicled flap reconstruction was associated with a higher risk of deep vein thrombosis (odds ratio [OR] = 2.64, confidence interval [CI] 1.02-6.85,  Myocutaneous pedicled flaps are associated with higher overall short-term postoperative complications compared with free flaps in head and neck reconstruction, which demonstrate a more favorable morbidity profile without significantly impacting hospital readmission, reoperation, or length-of-stay.

Sections du résumé

BACKGROUND BACKGROUND
 Microsurgical free flaps have largely supplanted pedicled flaps as the gold standard for head and neck cancer reconstruction. However, incidence of postoperative complications after accounting for patient comorbidities based on choice of reconstruction has not been well-defined in the literature in recent years.
METHODS METHODS
 Patients undergoing head and neck reconstruction were identified in the 2011-2016 ACS-NSQIP (American College of Surgeons National Surgical Quality Improvement Program) database and stratified into groups by free flap, myocutaneous pedicled flap, and other reconstruction. Demographics were analyzed and covariates balanced using overlap propensity score-based weighting. Logistic regression was used for binary outcomes and Gamma generalized linear model was used for length of stay.
RESULTS RESULTS
 A total of 4,712 patients met inclusion criteria out of which 1,297 patients (28%) underwent free flap, 208 patients (4%) pedicled flap, and 3,207 patients (68%) had other, or no reconstruction performed. After adjusting for patient and disease-specific factors, pedicled flap reconstruction was associated with a higher risk of deep vein thrombosis (odds ratio [OR] = 2.64, confidence interval [CI] 1.02-6.85,
CONCLUSION CONCLUSIONS
 Myocutaneous pedicled flaps are associated with higher overall short-term postoperative complications compared with free flaps in head and neck reconstruction, which demonstrate a more favorable morbidity profile without significantly impacting hospital readmission, reoperation, or length-of-stay.

Identifiants

pubmed: 34404103
doi: 10.1055/s-0041-1733922
pmc: PMC9073753
mid: NIHMS1795831
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

343-360

Subventions

Organisme : NCI NIH HHS
ID : P30 CA006927
Pays : United States
Organisme : P30CA006927
ID : National Institutes of Health National Cancer Institute

Informations de copyright

Thieme. All rights reserved.

Déclaration de conflit d'intérêts

None declared.

Références

Am J Surg. 1992 Dec;164(6):615-8
pubmed: 1463111
Otolaryngol Head Neck Surg. 2016 Jun;154(6):1014-8
pubmed: 26980913
J Craniofac Surg. 2015 Sep;26(6):e527-30
pubmed: 26335316
Head Neck. 2004 Nov;26(11):930-6
pubmed: 15508120
Acta Otorhinolaryngol Ital. 2012 Oct;32(5):288-96
pubmed: 23326007
Plast Reconstr Surg. 2000 Jun;105(7):2331-46; discussion 2347-8
pubmed: 10845285
Microsurgery. 2017 Jan;37(1):12-20
pubmed: 25752264
J Craniofac Surg. 2008 Nov;19(6):1577-82
pubmed: 19098555
Laryngoscope. 2006 Feb;116(2):173-81
pubmed: 16467700
Head Neck. 2012 Sep;34(9):1299-305
pubmed: 22021122
Microsurgery. 2018 Jul;38(5):504-511
pubmed: 29218804
Head Neck. 1991 May-Jun;13(3):213-6
pubmed: 2037473
Head Neck. 2010 Sep;32(9):1236-45
pubmed: 20014446
Head Neck. 2017 Apr;39(4):702-707
pubmed: 28000297
JAMA Facial Plast Surg. 2018 May 01;20(3):188-195
pubmed: 28983575
J Otolaryngol Head Neck Surg. 2019 Mar 14;48(1):13
pubmed: 30871637
Otolaryngol Head Neck Surg. 2014 Jan;150(1):87-94
pubmed: 24197930
Am J Epidemiol. 2019 Jan 1;188(1):250-257
pubmed: 30189042
JAMA Surg. 2018 Aug 1;153(8):764-765
pubmed: 29617521
Ann Plast Surg. 2005 Oct;55(4):384-8
pubmed: 16186704
Oral Oncol. 2009 Dec;45(12):1028-31
pubmed: 19796982
JAMA. 2020 Jun 16;323(23):2417-2418
pubmed: 32369102
Laryngoscope. 2001 Jul;111(7):1192-6
pubmed: 11568540
Arch Otolaryngol Head Neck Surg. 2011 Jan;137(1):82-7
pubmed: 21242553
Sci Rep. 2017 Apr 07;7:46256
pubmed: 28387356
Semin Plast Surg. 2010 May;24(2):148-54
pubmed: 22550435
Head Neck. 2019 Sep;41(9):3457-3463
pubmed: 31286627
Plast Reconstr Surg. 2010 Dec;126(6):1947-1959
pubmed: 20697315
J Reconstr Microsurg. 2019 Sep;35(7):516-521
pubmed: 31067582
CA Cancer J Clin. 2017 Jan;67(1):7-30
pubmed: 28055103
Plast Reconstr Surg. 2000 Sep;106(3):672-82; quiz 683
pubmed: 10987478
Surg Oncol Clin N Am. 2015 Jul;24(3):473-89
pubmed: 25979395
J Plast Surg Hand Surg. 2016 Aug;50(4):227-32
pubmed: 26983038
Plast Reconstr Surg. 2012 Feb;129(2):438-441
pubmed: 22286426
Int J Oral Maxillofac Surg. 2006 Mar;35(3):199-207
pubmed: 16293398
Plast Reconstr Surg. 2009 Jul;124(1):115-123
pubmed: 19568050
Plast Reconstr Surg. 2006 Oct;118(5):122e-133e
pubmed: 17016169
Acta Otorhinolaryngol Ital. 2016 Dec;36(6):459-468
pubmed: 28177328
Plast Reconstr Surg Glob Open. 2020 Apr 27;8(4):e2769
pubmed: 32440436

Auteurs

Jacob Y Katsnelson (JY)

Department of Surgery, Abington-Jefferson Health, Abington, Pennsylvania.

Richard Tyrell (R)

Division of Plastic and Reconstructive Surgery, Lewis Katz School of Medicine, Temple University, Philadelphia, Pennsylvania.

Murad J Karadsheh (MJ)

Department of Surgery, Einstein Healthcare Network, Philadelphia, Pennsylvania.

Ely Manstein (E)

Division of Plastic and Reconstructive Surgery, Lewis Katz School of Medicine, Temple University, Philadelphia, Pennsylvania.

Brian Egleston (B)

Biostatistics and Bioinformatics Facility, Temple University Health System, Fox Chase Cancer Center, Philadelphia, Pennsylvania.

Mengying Deng (M)

Biostatistics and Bioinformatics Facility, Temple University Health System, Fox Chase Cancer Center, Philadelphia, Pennsylvania.

Pablo A Baltodano (PA)

Division of Plastic and Reconstructive Surgery, Department of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania.

M Shuja Shafqat (MS)

Division of Plastic and Reconstructive Surgery, Lewis Katz School of Medicine, Temple University, Philadelphia, Pennsylvania.
Department of Surgery, Einstein Healthcare Network, Philadelphia, Pennsylvania.
Division of Plastic and Reconstructive Surgery, Department of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania.

Sameer A Patel (SA)

Division of Plastic and Reconstructive Surgery, Lewis Katz School of Medicine, Temple University, Philadelphia, Pennsylvania.
Department of Surgery, Einstein Healthcare Network, Philadelphia, Pennsylvania.
Division of Plastic and Reconstructive Surgery, Department of Surgical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH